Key Bullet Points:
- Apple (AAPL) surged to a new all-time high of $332.79 (+1.6% Thursday, +4% Wednesday), making it the strongest performer in the Dow for the second straight day — China approved Apple Intelligence for iPhones, Citi upgraded the stock, and a judge dismissed a $32.8 billion lawsuit — putting Apple just 4% from joining Nvidia in the exclusive $5 trillion club
- TSMC reported record Q2 profit — EPS $4.31 per ADR (beating estimates), revenue $40.2 billion (+36% YoY) — and pledged an additional $100 billion in Arizona chip factories on top of $165 billion already committed, but the stock fell 2.1% as the raised capex forecast of $60-64 billion spooked investors
- The Nasdaq sank 1% to 26,054 as the semiconductor selloff deepened — Marvell crashed 8.7%, AMD fell 4.2%, and the SOX index dropped 3.5% despite TSMC's blowout quarter — with hyperscaler capex revision fears now spreading across the entire chip sector
- UnitedHealth crushed Q2 and raised guidance (+7%), Abbott beat and raised full-year EPS (+12.1%), ManpowerGroup surged 33%, and Eli Lilly announced a $2.8 billion acquisition of psychedelic drugmaker AtaiBeckley — the biggest pharma bet on psychedelics in history
- Trump expanded U.S. airstrikes into northern Iran for the first time and U.S. forces fired Hellfire missiles to disable an oil tanker attempting to reach an Iranian port — but Iran released detained U.S. citizen Dena Karari after nearly two years, signaling a possible path toward de-escalation
Apple Breaks Out While Everything Else Breaks Down
There is a chart pattern forming on Wall Street that should terrify anyone who thinks they understand this market.
Apple closed Thursday at a new all-time high of $332.79, extending a two-day rally that has added more than $250 billion in market capitalization. On Wednesday, the stock surged 4% to $327.50. On Thursday it added another 1.6%, touching an intraday high of $332.37 before closing just above it.
What triggered the breakout? Everything, all at once.
China's cyberspace regulator approved Apple Intelligence for use on iPhones in the country — using AI models from Alibaba and Baidu — unlocking the world's largest smartphone market for Apple's AI features. Citi upgraded the stock. A federal judge threw out a $32.8 billion lawsuit related to child safety on iCloud. And Apple's own guidance — projecting 15% revenue growth and free cash flow near a record $140 billion — reminded investors that this is still the most reliable cash machine in the history of capitalism.
Apple is now roughly 4% away from joining Nvidia in the $5 trillion club. If it gets there, they will be the only two companies in history to reach that level. It was the strongest performer in the Dow on both days.
But here is the terrifying part: the Nasdaq fell 1% on Thursday.
TSMC Just Proved the Bull Case and Nobody Cared
Taiwan Semiconductor Manufacturing Company — the company that fabricates nearly every advanced chip on the planet — delivered record second-quarter results Thursday morning. Revenue hit $40.2 billion, beating the $39.63 billion consensus. Earnings per ADR unit came in at $4.31, ahead of estimates. Revenue surged 36% year-over-year, powered by insatiable demand for AI chips.
And then TSMC did something extraordinary: it pledged an additional $100 billion in investment for chip factories in Arizona, on top of the $165 billion already committed. That is $265 billion in total U.S. semiconductor investment from a single company.
The stock fell 2.1%.
Investors didn't sell on the earnings. They sold on the capex. TSMC raised its 2026 capital budget to a range of $60 billion to $64 billion — a signal that AI chip demand is so intense the company must spend at a pace that compresses future margins. For a market already nervous about whether hyperscaler AI spending is producing real returns, the message was clear: the tab is getting bigger, and nobody knows when it gets paid back.
The Chip Selloff That Won't Stop
TSMC's capex hike was gasoline on a fire that had already been burning for days.
The Philadelphia Semiconductor Index dropped another 3.5% on Thursday, extending a multi-day rout that has now wiped out hundreds of billions in chip stock valuations. Marvell Technology crashed 8.7% — its stock has been cut by nearly a third in one month despite a 125% year-to-date run. AMD fell 4.2%. Broadcom and Intel slid. Even Nvidia, the last domino standing, barely held flat.
The catalyst? Hyperscaler capex revision fears. News flow around revised capital expenditure forecasts from major cloud providers put the entire custom AI silicon trade on the defensive. The concern is simple: if the biggest AI spenders — Google, Amazon, Microsoft, Meta — start slowing their chip orders or shifting to in-house silicon, every company that has been riding the AI hardware wave faces a repricing.
The paradox is impossible to ignore. TSMC just reported the strongest evidence yet that AI chip demand is real and growing. But the market is no longer paying for growth at any price. It wants proof of return on investment — and it wants it now.
Earnings Keep Beating, From Hospitals to Psychedelics
Outside of chips, earnings season continued to deliver.
UnitedHealth Group crushed its Q2 results and raised full-year guidance, sending the stock up more than 7%. Abbott Laboratories beat estimates and lifted its earnings outlook to $5.45–$5.60 per share, surging 12.1%. ManpowerGroup, the employment agency, exploded 33% higher after posting a turnaround quarter and projecting revenue growth of 2%–6%.
But the most stunning deal came from Eli Lilly. The pharmaceutical giant announced it would acquire AtaiBeckley, a psychedelic drug developer, for $2.8 billion upfront — with the total deal potentially reaching $3.8 billion including milestones. AtaiBeckley's stock surged 33%.
The deal marks the largest pharmaceutical bet on psychedelic medicine in history. Lilly is joining Johnson & Johnson in targeting treatment-resistant depression with compounds once dismissed as fringe science, validating a market that barely existed five years ago.
Trump Goes North — and Iran Blinks
The U.S.-Iran conflict took a dramatic turn on both ends of the escalation spectrum Thursday.
On the military front, U.S. Central Command expanded its airstrike campaign into northern Iran for the first time, launching a seven-hour wave of strikes across multiple locations to "degrade Iran's ability to threaten innocent mariners." U.S. forces also fired Hellfire missiles at an oil tanker attempting to sail toward an Iranian port through the Strait of Hormuz, disabling the vessel.
Iran warned that the Strait was a "red line" and vowed retaliation.
But in the same 24-hour window, a quieter signal emerged. Iran released Dena Karari, a U.S.-Iranian citizen who had been detained on espionage allegations since 2024. President Trump announced the release on social media as strikes continued — a gesture that analysts interpreted as a possible backchannel signal toward de-escalation.
Brent crude eased slightly to around $84.80 after four consecutive days of gains. WTI slipped to $79.50. The prisoner release cooled the oil premium at the margins — but with Hellfire missiles hitting tankers and strikes reaching deeper into Iranian territory, no one on the trading floor was betting on peace.
Thursday's session closed with the Dow up 0.28% to 52,806, the S&P 500 down 0.39% to 7,543, and the Nasdaq down 1% to 26,054. The SOX semiconductor index fell 3.5%. Apple hit a new all-time high. Netflix reports Q2 after the close.
The market is splitting in half. And this time, nobody is pretending it isn't.
Found this helpful? Share it with others.